Cardiome Announces Publication of Independent Study Comparing BRINAVESS to Ibutilide in Patients with Recent-Onset Atrial Fibrillation

- Health
  0

NASDAQ: CRME   TSX: COM

VANCOUVER, March 31, 2016 /CNW/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the publication of results from an open label, single-center, randomized controlled study conducted by independent researchers at the Medical University…